Capricor Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Capricor Therapeutics Inc's ROI in the first quarter of 2026?
Capricor Therapeutics Inc recorded a cumulative net loss of $-115 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -56.17%.

Within the Healthcare sector 521 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 3085 to 3769.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Investment Change TTM	114.02 %	156.71 %	259.91 %	565.52 %	481.16 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	293	320	98	105	144
Return On Investment (TTM)	-56.17 %	-62.93 %	-65.99 %	-59.51 %	-57.77 %
CAPR's Overall Ranking	# 3769	# 3085	# 3514	# 3128	# 3558
Seq. Investment Change TTM	22.22 %	34.34 %	5.67 %	23.36 %	46.61 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-115	-105	-82	-70	-55

CAPR Company Profile >> Back to CAPR Roi Comparisons >> See Annual CAPR Return On Investment

Return On Investment CAPR's Ranking
Within:	No.
Industry	# 218
Sector	# 522
Overall	# 3769

Return On Investment Statistics
High	Average	Low
47.54 %	-90.46 %	-297.57 %
(Dec 31 2017)		(Sep 30 2017)

News about Capricor Therapeutics inc Return on Investment ROI

Capricor Therapeutics' Inclusion in Russell 2000 and Russell 3000 Indexes Puts It on the Map for Revolutionary Rare Disease Therapeutics

July 1, 2024

Capricor Therapeutics Set to Join Russell 2000 and Russell 3000 Indexes
San Diego-based biotechnology company, Capricor Therapeutics (NASDAQ: CAPR), has announced its inclusion in the prestigious Russell 2000 Index and the broad-market Russell 3000 Index, effective from July 1, 2024. Capricor Therapeutics is focused on developing revolutionary cell and exosome-based therapeutics for the treatment of rare diseases, marking a significant milestone for the company s growth and recognition within the industry.
Capricor Therapeutics successful inclusion in these renowned indexes highlights the company s positive trajectory and potential for future success. The Russell 2000 Index includes 2,000 small-cap stocks and serves as a benchmark for investors seeking exposure to small-cap companies. The Russell 3000 Index, a broader market index, comprises 3,000 of the largest publicly traded US companies, providing a comprehensive measure of the entire US stock market.

Financial Statements
Capricor Therapeutics Inc's I. Quarter Investments	$ 293 Millions	CAPR's Balance sheet
Capricor Therapeutics Inc's I. Quarter Income	$ -34 Millions	Quarterly CAPR's Income Statement
CAPR's Income by Division		See CAPR's Income by Division

CAPR Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	320	149	27	27	35
Y / Y Investment Growth	114.19 %	444.17 %	3.61 %	-23.7 %	9.79 %
Net Income in Millions	-105	-40	-22	-29	-20
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-32.81 %	-27.08 %	-81.15 %	-109.47 %	-57.63 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CAPR's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CAPR's Competitors
Subscribers only: Roi for Capricor Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CAPR's Customers

Other Ratios
CAPR's Roa	CAPR's Inventory Turnover Ratio	CAPR's Growth Rates	CAPR's Dividend Statistics
	CAPR's Profitability Ratios	CAPR's Asset Turnover Ratio	CAPR's Dividend Growth
CAPR's Roe	CAPR's Valuation Ratios	CAPR's Financial Strength Ratios	CAPR's Dividend Payout Ratio

Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:11:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.